Takeda Pharmaceutical Co., Ltd. (TAK)
14.37
+0.11
(+0.77%)
USD |
NYSE |
Dec 10, 16:00
14.37
0.00 (0.00%)
Pre-Market: 09:08
Takeda Pharmaceutical Enterprise Value: 72.23B for Dec. 10, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Pfizer Inc. | 193.60B |
| Bristol Myers Squibb Co. | 138.84B |
| Johnson & Johnson | 524.85B |
| Novartis AG | 274.42B |
| Sanofi | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -79.53M |
| Revenue (Quarterly) | 7.546B |
| Total Expenses (Quarterly) | 7.626B |
| EPS Diluted (Quarterly) | -0.0253 |
| Gross Profit Margin (Quarterly) | 47.41% |
| Profit Margin (Quarterly) | -1.05% |
| Earnings Yield | 0.55% |
| Operating Earnings Yield | 7.15% |
| Normalized Earnings Yield | 1.298 |